Availability of Endothelial Von Willebrand Factor and Platelet Function in Diabetic Patients Infused with a Vasopressin Analogue

Overview

Journal Diabetologia

Specialty Endocrinology

Date 1982 Nov 1

PMID 6816652

Citations 5

Authors

M Porta

Affiliations

Soon will be listed here.

Abstract

Acute release of von Willebrand factor and its immunologically detected correspondent, factor VIII-related antigen, from the endothelial cells into the circulation was induced by an infusion of 1-deamino-8-D-arginine vasopressin in eight normal subjects and eight insulin-dependent diabetic patients. The patients had higher basal levels of von Willebrand factor (140 +/- 13%) and VIII-related antigen (112 +/- 18%) than the normal subjects (95 +/- 5% and 70 +/- 8%, respectively). 1-deamino-8-D-arginine vasopressin induced a two-fold rise of these levels in both groups, von Willebrand factor/VIII-related antigen remaining higher in the diabetic patients throughout the experiment. In the normal subjects, platelet retention in glass bead columns increased soon after the infusion but returned to basal values after 2 h. In the patients, it remained high at the end of the infusion. No changes in platelet aggregation occurred. These results suggest that increased plasma von Willebrand factor/VIII-related antigen in diabetic patients is accompanied by an increased endothelial content of this factor.

Citing Articles

The role of endothelium in the pathogenesis of diabetic microangiopathy.

La Selva M, Beltramo E, Passera P, Porta M, MOLINATTI G Acta Diabetol. 1993; 30(4):190-200.

PMID: 8180411 DOI: 10.1007/BF00569929.

A study of platelet-relevant parameters in patients with diabetic microangiopathy.

Porta M, Peters A, Cousins S, Cagliero E, Fitzpatrick M, Kohner E Diabetologia. 1983; 25(1):21-5.

PMID: 6224713 DOI: 10.1007/BF00251891.

Increased thromboplastic potential in diabetes: a multifactorial phenomenon.

Ladik T, Smolka B, Bock T, Schramm W, Spannagl M, Landgraf R Klin Wochenschr. 1987; 65(13):600-6.

PMID: 3626428 DOI: 10.1007/BF01726667.

Endothelial cell function in diabetic microangiopathy.

Porta M, La Selva M, Molinatti P, MOLINATTI G Diabetologia. 1987; 30(8):601-9.

PMID: 3308602 DOI: 10.1007/BF00277315.

Increased platelet volume--sign of impaired thrombopoiesis in diabetes mellitus.

Tschope D, Langer E, Schauseil S, Rosen P, Kaufmann L, Gries F Klin Wochenschr. 1989; 67(4):253-9.

PMID: 2927060 DOI: 10.1007/BF01717328.

References

Salzman E . MEASUREMENT OF PLATELET ADHESIVENESS. A SIMPLE IN VITRO TECHNIQUE DEMONSTRATING AN ABNORMALITY IN VON WILLEBRAND'S DISEASE. J Lab Clin Med. 1963; 62:724-35. View

Porta M, Maneschi F, White M, Kohner E . Twenty-four hour variations of von Willebrand factor and factor VIII-related antigen in diabetic retinopathy. Metabolism. 1981; 30(7):695-9. DOI: 10.1016/0026-0495(81)90085-8. View

Porta M, Cagliero E, Kohner E . Is the pro-adhesive activity of plasma von Willebrand factor counteracted by a physiological inhibitor of platelet adhesiveness?. Clin Sci (Lond). 1982; 62(2):239-42. DOI: 10.1042/cs0620239. View

Mannucci P, Ruggeri Z, Pareti F, Capitanio A . 1-Deamino-8-d-arginine vasopressin: a new pharmacological approach to the management of haemophilia and von Willebrands' diseases. Lancet. 1977; 1(8017):869-72. DOI: 10.1016/s0140-6736(77)91197-7. View

ODEGAARD A, HELLEM A . INCREASED ACTIVIY OF "ANTI-WILLEBRAND FACTOR" IN DIABETIC PLASMA. Thromb Diath Haemorrh. 1964; 11:27-37. View

Cash J, Gader A, Mulder J, CORT J . Structure--activity relations of the fibrinolytic response to vasopressins in man. Clin Sci Mol Med. 1978; 54(4):403-9. DOI: 10.1042/cs0540403. View

Porta M, Townsend C, Clover G, Nanson M, Alderson A, McCraw A . Evidence for functional endothelial cell damage in early diabetic retinopathy. Diabetologia. 1981; 20(6):597-601. DOI: 10.1007/BF00257426. View

Mayne E, Bridges J, Weaver J . Platelet adhesiveness, plasma fibrinogen and factor 8 levels in diabetes mellitus. Diabetologia. 1970; 6(4):436-40. DOI: 10.1007/BF01212078. View

Petersen H, Gormsen J . Platelet aggregation in diabetes mellitus. Acta Med Scand. 1978; 203(1-2):125-30. DOI: 10.1111/j.0954-6820.1978.tb14842.x. View

10.

Porta M, Hilgard P, Kohner E . Platelet shape change abnormalities in diabetic retinopathy. Diabetologia. 1980; 18(3):217-21. DOI: 10.1007/BF00251919. View

11.

Menon C, Berry E, Ockelford P . Beneficial effect of D.D.A.V.P. on bleeding-time in von Willebrand's disease. Lancet. 1978; 2(8092 Pt 1):743-4. DOI: 10.1016/s0140-6736(78)92749-6. View

12.

Coller B, Frank R, Milton R, Gralnick H . Plasma cofactors of platelet function: correlation with diabetic retinopathy and hemoglobins Ala-c. Ann Intern Med. 1978; 88(3):311-6. DOI: 10.7326/0003-4819-88-3-311. View

13.

Gensini G, Abbate R, Favilla S, NERI SERNERI G . Changes of platelet function and blood clotting in diabetes mellitus. Thromb Haemost. 1979; 42(3):983-93. View

14.

Corbella E, Miragliotta G, Masperi R, Villa S, Bini A, de Gaetano G . Platelet aggregation and antithrombin III levels in diabetic children. Haemostasis. 1979; 8(1):30-7. DOI: 10.1159/000214288. View

15.

Heath H, Brigden W, Canever J, Pollock J, Hunter P, Kelsey J . Platelet adhesiveness and aggregation in relation to diabetic retinopathy. Diabetologia. 1971; 7(5):308-15. DOI: 10.1007/BF01219463. View

16.

LAURELL C . Electroimmuno assay. Scand J Clin Lab Invest Suppl. 1972; 124:21-37. DOI: 10.3109/00365517209102748. View

17.

Almer L, Pandolfi M . Fibrinolysis and diabetic retinopathy. Diabetes. 1976; 25(2 SUPPL):807-10. View

18.

Nilsson I, Walter H, Mikaelsson M, Vilhardt H . Factor VIII concentrate prepared from DDAVP stimulated blood donor plasma. Scand J Haematol. 1979; 22(1):42-6. DOI: 10.1111/j.1600-0609.1979.tb00398.x. View

19.

Preston F, Whipps S, Jackson C, French A, Wyld P, Stoddard C . Inhibition of prostacyclin and platelet thromboxane A2 after low-dose aspirin. N Engl J Med. 1981; 304(2):76-9. DOI: 10.1056/NEJM198101083040203. View

20.

Bensoussan D, Levy Toledano S, Passa P, Caen J, Caniver J . Platelet hyperaggregation and increased plasma level of Von Willebrand factor in diabetics with retinopathy. Diabetologia. 1975; 11(4):307-12. DOI: 10.1007/BF00422396. View